Velocity’s research site in Savannah frequently conducts clinical trials related to vaccines and a broad range of health conditions. Acquired by Velocity in 2022, this location was founded in 2012 as part of Meridian Clinical Research. Located near several other medical offices and minutes from a local hospital, the site is easily accessible to thousands of patients, including diverse populations.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Savannah team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.